Corner Office Conversation with Ravi Kant Jai...

India's semaglutide moment has arrived. As Novo Nordisk's patent expires on March 20th, over fifty generic brands are poised to flood the market potentially slashing monthly costs from ₹10,000 to ₹3,500. But this is no ordinary generic wave. Semaglutide is a complex peptide, cold ...  Show more

Anthropic refused the Pentagon unrestricted access to its Claude AI, and the fallout reshaped the tech-defense landscape overnight. OpenAI rushed in to fill the void, signing a classified deal that triggered internal resignations and a user exodus toward Claude. Host Himanshi Loh ...  Show more

Peu connu en dehors d’Asie, l'indien Gautam Adani, il y a peu troisième fortune mondiale, voit son empire se fissurer. Dans « La Story », le podcast d’actualité des « Echos », Pierrick Fay et ses invités livrent les clés d’une affaire qui sème le doute sur ...

We're excited to announce the launch of TalkCast, a daily podcast segment on Talk 100.3, a new talk radio station from the Fun Asia Network. Our CEO Chirag Desai joined morning show RJ's Vicky Sanil and Sobia Khan to talk about the new segment. Learn more about your ad choices. V ...  Show more

The Assignment is taking a short break, we’ll be back with new episodes on March 23rd. In the meantime, we want to highlight the good work of some our colleagues and partners. This week, Chasing Life with Dr. Sanjay Gupta. In this sixth season, he explores how technology has disr ...  Show more

Andy calls up Ashish Jha, Dean of Brown University's School of Public Health, to discuss what to expect during the next three stages of the pandemic. Ashish also describes going through what he calls "among the most surreal experiences of my life" – testifying in front of the Sen ...  Show more